Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
Not Applicable
Completed
- Conditions
- IBS - Irritable Bowel Syndrome
- Registration Number
- NCT03948854
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Researchers are trying to determine the best course of action regarding the dietary management with a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP diet) for irritable bowel syndrome.
- Detailed Description
An analysis of different educational programs providing information on the low FODMAP diet will be performed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
- Adult subjects (18-75 years) seen in the primary care clinic or in the Gastroenterology clinic at Mayo Clinic Florida, who are diagnosed with IBS by Rome IV criteria
Exclusion Criteria
- Subjects who have previously tried the low FODMAP diet (whether successful or not)
- Current or recent (less than 4 weeks) opioid use
- Current or recent (less than 10 weeks) rifaximin use
- Inability to speak or read English
- Pregnancy and/or breast-feeding
- Medical or psychological issues that would prevent modifying their diet for 8 weeks.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Improvement in IBS symptoms Baseline, end of study approximately 8 to 10 weeks Change in IBS symptoms will be measured from baseline to the end of study using the validated IBS symptoms severity scale (IBS-SS). This is a visual analog scale from 0-100. The primary outcome measure is improvement in symptom scores from end of study to baseline.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States
Mayo Clinic in Florida🇺🇸Jacksonville, Florida, United States